Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.51 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | F7 | P08709 | 3/20 | 0.49 |
| ▸ | F3 | P13726 | 3/20 | 0.49 |
| ▸ | FABP3 | P05413 | 3/20 | 0.49 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | PPARD | Q03181 | 2/20 | 0.49 |
| ▸ | PPARA | Q07869 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | FABP4 | P15090 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20018254 | 1.00 | CNR1 (0.51) | CNR1MGLLALDH1A1KDM4EF7 | |
| SCHEMBL31685534 | 0.92 | MGLL (0.54) | CNR1MGLLALDH1A1KDM4EF7 | |
| SCHEMBL20149657 | 0.88 | DNM1 (0.57) | CNR1MGLLALDH1A1EPHX2MAPT | |
| SCHEMBL25774127 | 0.87 | DNM1 (0.56) | LMNAMAPTTHRB | |
| SCHEMBL25774107 | 0.87 | MGLL (0.44) | CNR1MGLLALDH1A1HPGDHTR2A | |
| SCHEMBL20146345 | 0.86 | CNR1 (0.50) | CNR1ALDH1A1KDM4EF7F3 | |
| SCHEMBL24728770 | 0.86 | ALDH1A1 (0.51) | MGLLALDH1A1KDM4EF7F3 | |
| SCHEMBL27903374 | 0.85 | CNR1 (0.62) | CNR1MGLLALDH1A1KDM4EF7 | |
| SCHEMBL29312920 | 0.85 | CNR1 (0.50) | CNR1MGLLALDH1A1KDM4EF7 | |
| SCHEMBL6448523 | 0.84 | TERT (0.54) | F7F3FABP3PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250162978-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | UNIV RAMOT (IL) | 2025-05-22 | — | — | US | claimed |
| US-20240408032-A1 | LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2024-12-12 | — | — | US | claimed |
| EP-4398882-A1 | LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2024-07-17 | — | — | EP | claimed |
| CN-118265522-A | Lipid-based RNA formulations suitable for treatment | 生物技术欧洲股份公司 | 2024-06-28 | — | — | CN | claimed |
| US-20240033344-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME | BioNTech SE (DE) | 2024-02-01 | — | — | US | claimed |
| US-11851389-B2 | Cationic lipids for nucleic acid delivery and preparation thereof | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-12-26 | — | — | US | claimed |
| EP-4243787-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME | BioNTech SE (DE) | 2023-09-20 | — | — | EP | claimed |
| CN-110167922-B | Cationic lipids for nucleic acid delivery and preparation thereof | 特拉维夫大学拉莫特有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-116669709-A | Pharmaceutical composition comprising particles and mRNA and methods for preparing and storing the same | 生物技术公司 | 2023-08-29 | — | — | CN | claimed |
| WO-2023036960-A1 | LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2023-03-16 | — | — | WO | claimed |
| EP-3538515-B1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | UNIV RAMOT (IL) | 2022-07-20 | — | — | EP | claimed |
| WO-2022101486-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME | BioNTech SE (DE) | 2022-05-19 | — | — | WO | claimed |
| WO-2022101471-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING LIPID NANOPARTICLES AND MRNA, AND METHODS FOR PREPARING AND STORING THE SAME | BioNTech SE (DE) | 2022-05-19 | — | — | WO | claimed |
| US-20190292130-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2019-09-26 | — | — | US | claimed |
| EP-4456882-B1 | LIPID-BASED FORMULATIONS FOR ADMINISTRATION OF RNA | BioNTech SE (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4683642-A1 | STABILIZED NUCLEIC ACID COMPOSITIONS AND METHODS FOR PREPARING, STORING AND USING THE SAME | BioNTech SE (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20260021199-A1 | RNA LIPID NANOPARTICLES (LNPs) COMPRISING A POLYOXAZOLINE AND/OR POLYOXAZINE POLYMER | BioNTech SE (DE) | 2026-01-22 | — | — | US | disclosed |
| EP-3538515-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | Ramot at Tel-Aviv University Ltd. (IL) | 2019-09-18 | — | — | EP | disclosed |
| WO-2018087753-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2018-05-17 | — | — | WO | disclosed |
| WO-2018087753-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11851389-B2 | Cationic lipids for nucleic acid delivery and preparation thereof | NPC1L1, NPC1, CETP | CNR1 3460/4885MGLL 138/4885ALDH1A1 3981/4885 |
| US-20250162978-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | NPC1L1, NPC1, CETP | CNR1 3460/4885MGLL 138/4885ALDH1A1 3981/4885 |
| US-20190292130-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | NPC1L1, NPC1, CETP | CNR1 3460/4885MGLL 138/4885ALDH1A1 3981/4885 |
| US-20260021199-A1 | RNA LIPID NANOPARTICLES (LNPs) COMPRISING A POLYOXAZOLINE AND/OR POLYOXAZINE POLYMER | RNMT, NSUN2, RNGTT | CNR1 2535/4885MGLL 1007/4885ALDH1A1 4062/4885 |
| US-20240033344-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME | AUP1, SNRPA, SNRPF | CNR1 2670/4885MGLL 118/4885ALDH1A1 2735/4885 |
| US-20240408032-A1 | LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY | PHOSPHO1, PLIN3, SARNP | CNR1 3781/4885MGLL 355/4885ALDH1A1 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.